Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
US |
|
Transocean Ltd
NYSE:RIG
|
CH |
|
G
|
Goldhills Holding Ltd
XTSX:GHL
|
CA |
|
Corticeira Amorim SGPS SA
F:AS4
|
PT |
|
L
|
Laguna Resorts and Hotels PCL
SET:LRH
|
TH |
|
Nel ASA
OSE:NEL
|
NO |
|
P
|
Pfizer Inc
F:PFE
|
US |
Wall Street
Price Targets
REGN Price Targets Summary
Regeneron Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
REGN
is 880.4 USD
with a low forecast of 666.6 USD and a high forecast of 1 109.85 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is REGN's stock price target?
Price Target
880.4
USD
According to Wall Street analysts, the average 1-year price target for
REGN
is 880.4 USD
with a low forecast of 666.6 USD and a high forecast of 1 109.85 USD.
What is Regeneron Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
10%
For the last 14 years the
compound annual growth rate for
Regeneron Pharmaceuticals Inc's revenue is
28%.
The projected
CAGR
for the next 3 years is
10%.
What is Regeneron Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
23%
The
compound annual growth rate
of Regeneron Pharmaceuticals Inc's operating income for the next 3 years is
23%.
What is Regeneron Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
13%
The
compound annual growth rate
of Regeneron Pharmaceuticals Inc's net income for the next 3 years is
13%.
